Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Pascal Biosciences Inc (V: PAS)

 
PAS Technical Analysis
5
As on 2nd Feb 2023 PAS SHARE Price closed @ 0.02 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.08 & Strong Sell for SHORT-TERM with Stoploss of 0.10 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

PASSHARE Price

Open 0.02 Change Price %
High 0.02 1 Day 0.00 0.00
Low 0.02 1 Week 0.00 0.00
Close 0.02 1 Month 0.00 0.00
Volume N/A 1 Year -0.10 -83.33
52 Week High 0.14 | 52 Week Low 0.02
 
V Canada Most Active Stocks
SML 1435.70 0.53%
NU 10.36 -26.32%
TVI 0.02 0.00%
SNS 0.40 -2.44%
MJS 0.13 8.33%
TK 0.04 0.00%
AFM 0.88 1.15%
XTM 0.04 0.00%
SSE 0.01 %
SMN 0.08 0.00%
 
V Canada Top Gainers Stocks
BST 33.38 83350.00%
BST 33.38 83350.00%
BST 33.38 83350.00%
BST 33.38 83350.00%
BST 33.38 83350.00%
BST 33.38 83350.00%
BST 33.38 83350.00%
BST 33.38 83350.00%
BST 33.38 83350.00%
BST 33.38 83350.00%
 
V Canada Top Losers Stocks
VEC 43.92 -99.71%
VEC 43.92 -99.71%
VEC 43.92 -99.71%
VEC 43.92 -99.71%
TZR 0.05 -75.00%
KUR-H 0.03 -70.00%
SGMA 4.18 -63.65%
SGMA 4.18 -63.65%
ZBNI 0.04 -50.00%
PGC 0.02 -50.00%
 
 
PAS
Daily Charts		 PAS
Intraday Charts		 Whats New @
Bazaartrend		 PAS
Free Analysis
 
PAS Important Levels Intraday
RESISTANCE0.02
RESISTANCE0.02
RESISTANCE0.02
RESISTANCE0.02
RESISTANCE0.02
RESISTANCE0.02
RESISTANCE0.02
RESISTANCE0.02
 
PAS Forecast April 2025
Share
4th UP Forecast0.1
3rd UP Forecast0.07
2nd UP Forecast0.06
1st UP Forecast0.04
1st DOWN Forecast-0
2nd DOWN Forecast-0.02
3rd DOWN Forecast-0.03
4th DOWN Forecast-0.06
 
PAS Weekly Forecast
4th UP Forecast0.04
3rd UP Forecast0.03
2nd UP Forecast0.03
1st UP Forecast0.03
1st DOWN Forecast0.01
2nd DOWN Forecast0.01
3rd DOWN Forecast0.01
4th DOWN Forecast0.00
 
PAS Forecast2025
4th UP Forecast0.25
3rd UP Forecast0.18
2nd UP Forecast0.13
1st UP Forecast0.09
1st DOWN Forecast-0.05
2nd DOWN Forecast-0.09
3rd DOWN Forecast-0.14
4th DOWN Forecast-0.21
 
 
PAS Other Details
Segment EQ
Market Capital 5858532.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
PAS Address
PAS
 
PAS Latest News
 
Your Comments and Response on Pascal Biosciences Inc
 
PAS Business Profile
Pascal Biosciences Inc., a biotechnology company, researches and develops products for the treatment of cancer, and for the enhancement of immune system. Its development portfolio includes PAS-403, a small molecule therapeutic advancing into clinical trials for the treatment of glioblastoma; and PAS-393, an immuno-stimulatory cannabinoid to be used in combination with checkpoint inhibitor therapy for cancer treatment. The company is also developing a B-cell targeted antibody for acute lymphoblastic leukemia and B cell lymphomas; and cannabinoid therapeutic for the treatment of COVID-19. The company has an exclusive license agreement with the University of Washington to develop a cannabinoid-based product for the treatment of glioblastoma multiforme and brain metastases; and a collaborative research agreement with SoRSE Technology Corporation to advance PAS-393 into clinical testing. Pascal Biosciences Inc. was founded in 2013 and is headquartered in Vancouver, Canada. Address: 666 Burrard Street, Vancouver, BC, Canada, V6C 3P6
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service